Saving Money on Diabetes Medication with a Generic Substitute Finder
A person with type 2 diabetes in India often takes three or four medicines a day, forever. At branded prices, a monthly medicine bill can run ₹1,500 to ₹3,000. At Jan Aushadhi prices for the same salts, the same treatment often costs under ₹500. That is a difference of ₹15,000-30,000 a year for one household member — real money that mostly goes uncollected because nobody had the two-minute conversation at the pharmacy.
The common diabetes medicines and their generic prices
A rough snapshot at typical retail (branded) and Jan Aushadhi (generic) prices per month:
- Salt: Metformin 500 mg (twice a day) · Branded (monthly): ₹80–150 · Jan Aushadhi (monthly): ₹15–30 · Approximate saving: 80%
- Salt: Metformin 1000 mg SR (once a day) · Branded (monthly): ₹150–250 · Jan Aushadhi (monthly): ₹40–70 · Approximate saving: 70%
- Salt: Glimepiride 1 mg (once a day) · Branded (monthly): ₹100–180 · Jan Aushadhi (monthly): ₹20–40 · Approximate saving: 80%
- Salt: Sitagliptin 100 mg (once a day) · Branded (monthly): ₹400–700 · Jan Aushadhi (monthly): not available · Approximate saving: —
- Salt: Empagliflozin 10 mg (once a day) · Branded (monthly): ₹700–1,100 · Jan Aushadhi (monthly): not available · Approximate saving: —
- Salt: Human insulin (per vial, 40 IU/ml) · Branded (monthly): ₹150–200 · Jan Aushadhi (monthly): ₹95 (PMBJP) · Approximate saving: 40–50%
The exact figures vary by pharmacy, city and pack size, but the pattern is consistent — 60-80% cheaper for the medicines that have Jan Aushadhi versions.
What has generic versions and what does not
The older diabetes drugs — metformin, sulfonylureas, insulin — are widely available as generics and Jan Aushadhi versions. The newer classes — DPP-4 inhibitors, SGLT2 inhibitors, GLP-1 receptor agonists — are still under patent for many of the leading brands, so a like-for-like generic does not yet exist. For those, the saving is limited to switching between different branded products at the same salt.
The insulin conversation
Insulin is the medicine where the price difference is most consequential. A person on insulin who cannot afford it does not take it, and blood sugar spirals within days. The Jan Aushadhi insulin — Human Actrapid or Insulin-R and their equivalents — costs around ₹95 per vial vs ₹150-200 for the branded equivalent, and the storage requirements are the same. This is not a trade-off in outcomes; this is a different price for the same medicine.
What to do at the next diabetes review
Print your current medicine list with prices. Ask the doctor two questions:
- "Which of these have generic equivalents at the same salt and strength?"
- "Would you write the next prescription by salt name, not brand?"
Both questions are conservative, medically. Both save the family the price of one medicine bill within the first month of asking them.
The medicines where caution is warranted
For most diabetes medicines, generic substitution is straightforward. Two exceptions:
- Insulin brand switching — even between two well-manufactured versions — can occasionally require small dose adjustments during the transition. Do it deliberately with your endocrinologist, not on the pharmacist's suggestion.
- Sustained-release formulations of metformin (e.g. Glycomet SR, Glucobay SR) are not directly interchangeable with plain-release generic metformin. If the prescription says SR, the substitute must also be SR.
References
Free for 90 days, no card needed. After that, keeping the record costs ₹349 for the year.
General information, not medical advice. Always talk to a qualified doctor about your own care. Where this and your doctor disagree, your doctor is right.